Responsiveness of the neurodisability scale for meningoencephalitis of unknown origin in dogs.

Gonçalves, R ORCID: 0000-0001-5420-9801, Maddox, TW, Phillipps, S ORCID: 0000-0002-8061-4007, Carrete, JC, Anderson, FE, Bentley, RT ORCID: 0000-0001-7597-6436 and Walmsley, G (2025) Responsiveness of the neurodisability scale for meningoencephalitis of unknown origin in dogs. The Journal of small animal practice, 66 (11). pp. 767-772. ISSN 0022-4510, 1748-5827

Access the full-text of this item by clicking on the Open Access link.

Abstract

<h4>Objectives</h4>To determine the responsiveness of the neurodisability scale during the treatment of meningoencephalitis of unknown origin in dogs.<h4>Materials and methods</h4>The neurodisability scale score was determined at initial presentation and then repeated at each reassessment during treatment. At each visit, a subjective clinical evaluation of the response to treatment was also recorded. Responsiveness of the neurodisability scale between timepoints was evaluated using the receiver operating characteristics method and correlation analysis. Responsiveness was calculated between the neurodisability scale score at initial assessment and the first re-examination after starting treatment (T₁). It was also calculated between the neurodisability scale score at T₁ and a second reassessment (T₂) where the score had changed either due to relapse or further improvement (if no changes occurred, the last available assessment was used).<h4>Results</h4>Thirty-eight dogs were included. Median time between T₀ and T₁ was 3 weeks, and 35/38 had shown clinical improvement. Median time between T₁ and T₂ was 6 months; 13 dogs were suspected to have clinical relapse. The neurodisability scale demonstrated excellent responsiveness at both timepoints, with area under the curves of 0.96 (95% CI = 0.89 to 1) at T₁ and 0.93 (95% CI = 0.85 to 1) at T₂. There was also an excellent negative correlation coefficient produced by the change in score and the dogs' subjective clinical evaluation (T₀ - T₁ Gamma = -0.8 and T₁ - T₂ Gamma = -0.88).<h4>Clinical significance</h4>The neurodisability scale is a responsive monitoring tool during meningoencephalitis of unknown origin treatment and relapse. Our results support the utility of the neurodisability scale as a clinician-reported outcome measure for use in clinical trials.

Item Type:	Article
Uncontrolled Keywords:	Animals, Dogs, Meningoencephalitis, Dog Diseases, Treatment Outcome, Severity of Illness Index, Female, Male
Divisions:	Faculty of Health & Life Sciences Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences
Depositing User:	Symplectic Admin
Date Deposited:	08 Jul 2025 10:04
Last Modified:	15 Nov 2025 04:14
DOI:	10.1111/jsap.13889
Open Access URL:	https://doi.org/10.1111/jsap.13889
Related Websites:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3193626
Disclaimer:	The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.